201 related articles for article (PubMed ID: 12455302)
1. Efficacy and safety of almotriptan malate for migraine.
Balbisi EA
Am J Health Syst Pharm; 2002 Nov; 59(22):2184-93. PubMed ID: 12455302
[TBL] [Abstract][Full Text] [Related]
2. Spotlight on almotriptan in migraine.
Keam SJ; Goa KL; Figgitt DP
CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
[TBL] [Abstract][Full Text] [Related]
3. Almotriptan: a review of its use in migraine.
Keam SJ; Goa KL; Figgitt DP
Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
[TBL] [Abstract][Full Text] [Related]
4. Oral almotriptan in the treatment of migraine: safety and tolerability.
Dodick DW
Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
[TBL] [Abstract][Full Text] [Related]
5. Almotriptan: an effective and well-tolerated treatment for migraine pain.
Pascual J
Drugs Today (Barc); 2003; 39 Suppl D():31-6. PubMed ID: 15071618
[TBL] [Abstract][Full Text] [Related]
6. Almotriptan: pharmacological differences and clinical results.
Pascual J
Curr Med Res Opin; 2001; 17 Suppl 1():s63-7. PubMed ID: 12463281
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
Chen LC; Ashcroft DM
Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
[TBL] [Abstract][Full Text] [Related]
8. A review of the effects of almotriptan and other triptans on clinical trial outcomes that are meaningful to patients with migraine.
Mondell BE
Clin Ther; 2003 Feb; 25(2):331-41. PubMed ID: 12749502
[TBL] [Abstract][Full Text] [Related]
9. A review of the clinical efficacy and tolerability of almotriptan in acute migraine.
Dodick DW
Expert Opin Pharmacother; 2003 Jul; 4(7):1157-63. PubMed ID: 12831340
[TBL] [Abstract][Full Text] [Related]
10. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
[TBL] [Abstract][Full Text] [Related]
11. Tolerability and efficacy of almotriptan in the long-term treatment of migraine.
Pascual J; Falk R; Docekal R; Prusinski A; Jelencsik J; Cabarrocas X; Segarra X; Luria X; Ferrer P
Eur Neurol; 2001; 45(4):206-13. PubMed ID: 11385257
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the cost-effectiveness of almotriptan and sumatriptan in the treatment of acute migraine using a composite efficacy/tolerability end point.
Williams P; Reeder CE
J Manag Care Pharm; 2004; 10(3):259-65. PubMed ID: 15228377
[TBL] [Abstract][Full Text] [Related]
13. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.
Tfelt-Hansen P; De Vries P; Saxena PR
Drugs; 2000 Dec; 60(6):1259-87. PubMed ID: 11152011
[TBL] [Abstract][Full Text] [Related]
14. Treatment satisfaction, functional status, and health-related quality of life of migraine patients treated with almotriptan or sumatriptan.
Colman SS; Brod MI; Krishnamurthy A; Rowland CR; Jirgens KJ; Gomez-Mancilla B
Clin Ther; 2001 Jan; 23(1):127-45. PubMed ID: 11219473
[TBL] [Abstract][Full Text] [Related]
15. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
Mayo KW; Osterhaus JT
Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
[TBL] [Abstract][Full Text] [Related]
16. Almotriptan, a new anti-migraine agent: a review.
Gras J; Llenas J; Jansat JM; Jáuregui J; Cabarrocas X; Palacios JM
CNS Drug Rev; 2002; 8(3):217-34. PubMed ID: 12353056
[TBL] [Abstract][Full Text] [Related]
17. Almotriptan: a balanced approach to migraine.
Cull R
Hosp Med; 2001 Feb; 62(2):96-100. PubMed ID: 11236625
[TBL] [Abstract][Full Text] [Related]
18. Rizatriptan: a pharmacoeconomic review of its use in the acute treatment of migraine.
McCormack PL; Foster RH
Pharmacoeconomics; 2005; 23(12):1283-98. PubMed ID: 16336021
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of almotriptan and rizatriptan in the treatment of acute migraine.
Williams P; Reeder CE
Clin Ther; 2003 Nov; 25(11):2903-19. PubMed ID: 14693315
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of oral almotriptan: interim analysis of a 1-year open study.
Cabarrocas X; Esbri R; Peris F; Ferrer P
Headache; 2001 Jan; 41(1):57-62. PubMed ID: 11168604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]